Augusta, GEORGIA4 Active Studies

Leukemia Clinical Trials in Augusta, GEORGIA

Find 4 actively recruiting leukemia clinical trials in Augusta, GEORGIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
410
Enrolling

Recruiting Leukemia Studies in Augusta

RecruitingAugusta, GEORGIANCT04835584

KRT-232 and TKI Study in Chronic Myeloid Leukemia

This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with Ph+ Chronic Myeloid Leukemia (CML) who have relapsed or are refractory or intolerant to ...

109 participants
Kartos Therapeutics, Inc.
View Study Details
RecruitingAugusta, GEORGIANCT02781883

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete Remission \[CR\], Complete Remission with ...

108 participants
Bio-Path Holdings, Inc.
View Study Details
RecruitingAugusta, GEORGIANCT05143840

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

This study is a multicenter Phase 2, non-randomized, open-label single-group frontline study administering asciminib in patients with newly diagnosed Chronic Myeloid Leukemia-Chronic Phase (CML-CP). T...

100 participants
Augusta University
View Study Details
RecruitingAugusta, GEORGIANCT06672146

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

This phase II MyeloMATCH treatment trial studies how well ASTX727 and venetoclax plus enasidenib works compared to ASTX727 and venetoclax alone for the treatment of older patients with newly diagnosed...

93 participants
National Cancer Institute (NCI)
View Study Details

About Leukemia Clinical Trials in Augusta

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Augusta, GEORGIA. These studies are seeking a combined 410 participants. Research is being sponsored by Kartos Therapeutics, Inc., Bio-Path Holdings, Inc., Augusta University and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Augusta — FAQ

Are there leukemia clinical trials in Augusta?

Yes, there are 4 leukemia clinical trials currently recruiting in Augusta, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Augusta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.

Are clinical trials in Augusta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov